Bolt Biotherapeutics, Inc.
BOLT
$0.358
-$0.012-3.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -53.69% | -55.06% | -41.45% | -27.72% | -39.49% |
| Total Receivables | 34.58% | -84.82% | -50.00% | 80.00% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -32.71% | -27.53% | -37.89% | -40.70% | -28.95% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 371.35% | -- | -- | -- | -- |
| Total Current Assets | -51.93% | -54.45% | -41.35% | -27.77% | -38.81% |
|
|
|||||
| Total Current Assets | -51.93% | -54.45% | -41.35% | -27.77% | -38.81% |
| Net Property, Plant & Equipment | 3.40% | -19.18% | -17.51% | -16.58% | -15.59% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -70.91% | -59.19% | -19.56% | 35.87% | 38.30% |
| Total Assets | -37.65% | -37.65% | -34.88% | -30.70% | -29.86% |
|
|
|||||
| Total Accounts Payable | -49.55% | -59.75% | -23.54% | 20.93% | -16.89% |
| Total Accrued Expenses | -33.17% | -0.21% | -25.84% | -6.04% | -17.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -19.09% | 5.37% | 16.04% | 16.22% | 16.35% |
| Total Finance Division Other Current Liabilities | 70.56% | 72.76% | 192.23% | 19.19% | 10.44% |
| Total Other Current Liabilities | 70.56% | 72.76% | 192.23% | 19.19% | 10.44% |
| Total Current Liabilities | -22.49% | -3.56% | 1.60% | 2.89% | -11.51% |
|
|
|||||
| Total Current Liabilities | -22.49% | -3.56% | 1.60% | 2.89% | -11.51% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 31.66% | -15.54% | -15.85% | -14.76% | -13.76% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -60.44% | -61.97% | -62.51% | -57.95% | -29.41% |
| Total Liabilities | -9.80% | -20.79% | -21.10% | -20.13% | -16.44% |
|
|
|||||
| Common Stock & APIC | 1.58% | 1.79% | 2.05% | 1.98% | 2.03% |
| Retained Earnings | -17.33% | -18.79% | -20.04% | -20.20% | -23.45% |
| Treasury Stock & Other | 162.16% | 217.82% | 80.79% | 84.68% | 104.03% |
| Total Common Equity | -49.27% | -43.84% | -39.59% | -33.95% | -34.26% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -49.27% | -43.84% | -39.59% | -33.95% | -34.26% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -49.27% | -43.84% | -39.59% | -33.95% | -34.26% |
|
|
|||||